APA (7th ed.) Citation

Anastasopoulou, V., Schreiber, H., Lee, C., Kiyotani, K., Hansmann, L., Nakamura, Y., . . . Wolf, S. P. Mutant p53-specific CD8TCR-therapy combined with a CD4TCR prevents relapse of cancer and outgrowth of micrometastases. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Anastasopoulou, Vasiliki, Hans Schreiber, Ching-En Lee, Kazuma Kiyotani, Leo Hansmann, Yusuke Nakamura, Matthias Leisegang, and Steven P. Wolf. Mutant P53-specific CD8TCR-therapy Combined with a CD4TCR Prevents Relapse of Cancer and Outgrowth of Micrometastases. Taylor & Francis Group.

MLA (9th ed.) Citation

Anastasopoulou, Vasiliki, et al. Mutant P53-specific CD8TCR-therapy Combined with a CD4TCR Prevents Relapse of Cancer and Outgrowth of Micrometastases. Taylor & Francis Group.